Aqua Pharmaceuticals, an Almirall Company
Pharmaceutical Manufacturing • 
Eagleview, Pennsylvania, United States • 51-100 Employees
Company overview
| Headquarters | 707 Eagleview Blvd, Suite 2, Exton, PA 19341, US |
| Phone number | +12400008 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Skin Care, Psoriasis, Acne, North America, Atopic Dermatitis, Actinic Keratosis, Seborrheic Dermatitis, Corticosteroid Responsive Dermatoses, Therapeutic Dermatology |
| Founded | 2004 |
| Employees | 51-100 |
| Socials |
Key Contacts at Aqua Pharmaceuticals, an Almirall Company
Tony Cavallo
Executive Director, Provider Liaison Dept.
Alicia Cabrelli
Associate Director
Tracy Nguyen
Director
Darius Vasilionkaitis
Director
Aqua Pharmaceuticals, an Almirall Company Email Formats
Aqua Pharmaceuticals, an Almirall Company uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 48.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 48.2% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 24.1% |
{first name}@company.com | john@company.com | 12.4% |
{last name}.{first name}@company.com | doe.john@company.com | 8.9% |
{first name}{last name}@company.com | johndoe@company.com | 6.4% |
About Aqua Pharmaceuticals, an Almirall Company
Aqua Pharmaceuticals is a specialty dermatology company focusing on acquiring, developing and marketing prescription medical dermatology products in the United States. Currently marketed products include: ACTICLATE® (doxycycline hyclate USP) Tablets, CORDRAN® (flurandrenolide USP) Lotion, Cream, and Ointment, 0.05%, FLUOROPLEX® (fluorouracil) 1% Topical Cream, XOLEGEL® (ketaconazole) Gel, 2%, VERDESO® (desonide) Foam, 0.05%, and MONODOX® (doxycycline monohydrate) Capsules. An essential element in Aqua's strategy for strong, sustainable growth is to build beyond the current product portfolio by developing, licensing, and acquiring products for the treatment of skin conditions. Importantly, Aqua looks to expand its opportunities through product development, in-licensing, co-promotion, product or company acquisition, and partnerships. In December 2013, Almirall S.A. entered into a definitive agreement to acquire Aqua Pharmaceuticals. Almirall is a pharmaceutical company committed to provide valuable medicines through its own R&D efforts together with external partnerships, licenses, and collaborations. Through seeking innovative medicines, Almirall aims to be a relevant player in dermatology, in addition to having a strong interest in gastroenterology and pain. With more than 3,000 employees in 23 countries, Almirall generated total revenues of €825 million in 2013. The company was founded in 1943 and is headquartered in Barcelona, Spain. The stock is traded on the Spanish stock exchange (ticker: ALM).
Aqua Pharmaceuticals, an Almirall Company revenue & valuation
| Annual revenue | $25,400,000 |
| Revenue per employee | $438,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $81,300,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Aqua Pharmaceuticals, an Almirall Company has 27 employees across 6 departments.
Departments
Number of employees
Funding Data
Aqua Pharmaceuticals, an Almirall Company has never raised funding before.
Aqua Pharmaceuticals, an Almirall Company Tech Stack
Discover the technologies and tools that power Aqua Pharmaceuticals, an Almirall Company's digital infrastructure, from frameworks to analytics platforms.
CDN
Marketing automation
Advertising
PaaS
Programming languages
CMS
Cookie compliance
JavaScript libraries
Reverse proxies
Analytics
JavaScript frameworks
SSL/TLS certificate authorities
Canada
Italy
Frequently asked questions
4.8
40,000 users
